“Retrospective Clinical Evidence on Switching to Modern Sulfonylurea/Metformin in Patients Uncontrolled on DPP4i-based Therapies” (2024) Asian Journal of Diabetology, 24(4), pp. 9–17. doi:10.59793/hjthw688.